Current stock page

Stock Analysis

Abivax S.A. (ABVX) Stock Analysis

Abivax S.A. (ABVX) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

ABVX Stock Analysis Summary

Abivax S.A. (ABVX) currently has an AIQ Score of 35/100, indicating a bearish setup. Risk is the strongest factor at 37/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

ABVX at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$87.58
AIQ Score35/100
Overall ViewBearish
Technical Analysis ConsensusStrong Sell
Market Cap$6.98B
P/E Ratio (TTM)-16.79
Forward P/E—
EPS (Q2 FY2026)-$1.47
Revenue (Q2 FY2026)$0
Dividend Yield (TTM)0.00%
Beta1.18
Volume698.95K
52-week range$69.81-$148.83
RSI 1445.5
50-Day SMA$94.85
200-Day SMA$112.57
Analyst Price Target$141.33
Next EarningsDec 21, 2026
As of Nov 13, 2026 · Market close

ABVXAbivax S.A.

Healthcare / Biotechnology

Low Priority

In Line With Peers

BearishEdge 5/10
$87.58−$2.62 (−2.90%)

Latest quote

  • Momentum
    34
  • Value
    —
  • Quality
    35
  • Risk resilience
    37
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

ABVX Stock Analysis Summary

Abivax S.A. (ABVX) currently has an AIQ Score of 35/100, indicating a bearish setup. Risk resilience is the strongest factor at 37/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bearish

In a bearish regime, ABVX has AIQ Score of 35/100 with Risk resilience base of 37/100 and fading Momentum at 34/100. Wait for component alignment before adding exposure.

Healthcare · -2.90% stock move · ABVX classified in Biotechnology.

Current Evidence

BearishABVX is in a bearish AIQ regime; Risk resilience is the strongest visible factor at 37/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is ABVX Bullish or Bearish Right Now?

ABVX currently has a bearish overall setup. Risk Resilience is the strongest factor at 37/100, while Momentum is weakest at 34/100. The current evidence suggests a bearish setup.

Bull Case
  • - Analyst target implies +61.38% upside from the latest quote.
Bear Case
  • - Momentum is weak at 34/100.
  • - Risk Resilience is weak at 37/100.
  • - Price is -22.20% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (31 vs 7).

Current Consensus

ABVX's Technical Analysis Consensus is currently Strong Sell, with 7 buy, 8 neutral, and 31 sell votes. ABVX's 14-day RSI is 45.5, which places the stock in a neutral momentum range. ABVX's beta is 1.18, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in ABVX?

The largest recent change in ABVX is Momentum moving up by 3.0 points over the available 7-day comparison window. Risk Resilience remains the strongest visible factor.

AIQ Score
+1.0
Momentum
+3.0
Quality
+0.0
Risk
+0.0

What Would Change the ABVX Outlook?

The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

ABVX Decision Framework

Public evidence layers, setup checks, and risk context for Abivax S.A..

Abivax S.A. (ABVX) Stock Analysis

Abivax S.A. has an AIQ Score of 35/100 in a Bearish regime. Risk is strongest at 37/100. Beta is 1.18, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextABVX is in a Bearish AIQ regime with score 35/100.
Signal ConflictThe primary conflict is that risk leads at 37/100 while momentum lags at 34/100.
Factor EvidenceMomentum 34/100 · Quality 35/100 · Risk 37/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthFail

Risk is the strongest factor at 37/100.

TimingFail

Momentum is 34/100 and RSI (14) is 45.5.

Regime fitFail

ABVX is in a Bearish regime at 35/100.

Risk controlFail

Risk factor is 37/100 with beta 1.18 and annual volatility 86.44%.

ConflictPass

Current conflict: risk leads at 37/100 while momentum lags at 34/100.

AIQ Score
35/100
Price
$87.58
Beta
1.18
RSI (14)
45.5

ABVX Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

ABVX Fundamentals

ABVX valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$0
Net income
-$117.43M
Free cash flow
-$52.1M
View full ABVX fundamental analysis

ABVX Technical Analysis

ABVX technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
45.5
Price vs SMA-50
-7.66%
View full ABVX technical analysis

ABVX Stock Catalysts

Track ABVX earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Dec 21, 2026
Analyst target
$141.33
News items
0
View ABVX earnings and stock catalysts

ABVX Dividend Analysis

ABVX dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View ABVX dividend history and analysis

ABVX Financial Data

ABVX revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$0
EPS
-$1.47
Periods
8
View ABVX financials

ABVX Risk Analysis

ABVX volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.18
Risk score
37/100
1Y volatility
86.44%
View ABVX risk analysis

ABVX Stock News

ABVX stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read ABVX stock news

ABVX vs Biotechnology Peers

Current peer cohort: ABVX · ADMA · AGIO · ALMS · AMLX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
ABVX
Current stock
35/100—34/10037/1000.2486.44%Current
ADMA
ADMA Biologics, Inc.
78/10080/10091/10056/100-0.0158.93%ABVX vs ADMA
AGIO
Agios Pharmaceuticals, Inc.
56/10052/10061/10047/1000.0779.96%ABVX vs AGIO
ALMS
Alumis Inc.
20/100—13/10020/1000.65137.60%ABVX vs ALMS
AMLX
Amylyx Pharmaceuticals, Inc.
78/100—90/10048/1001.3587.03%ABVX vs AMLX
Pairwise Compare links: ADMA · AGIO · ALMS · AMLXABVX vs ADMAABVX vs AGIOABVX vs ALMSABVX vs AMLXCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a ABVX stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for ABVX: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-16.79
As of Nov 13, 2026
Revenue growth
—
Gross margin
153.15%
Current debt / equity
0
Latest quarterly evidence

Latest period Jun 30, 2026.

Review fundamentals
Quarter revenue
$0
Quarter net income
-$117.43M
Quarter free cash flow
-$52.1M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Mixed
RSI 14
45.5
MACD
-1.51

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
37/100
Beta
1.18
Annual volatility
86.44%
Max drawdown
-50.11%

ABVX Stock FAQ

What is ABVX stock price today?

Abivax S.A.'s current stock price is $87.58. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is ABVX bullish or bearish right now?

ABVX's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is ABVX's market cap?

ABVX's market cap is $6.98B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is ABVX's current P/E ratio?

ABVX's current P/E ratio is -16.79 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is ABVX's RSI?

ABVX's 14-day RSI is 45.5 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is ABVX above its 50-day and 200-day moving averages?

ABVX is -7.66% from its 50-day SMA and -22.20% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is ABVX's next earnings date?

ABVX's next earnings date is currently listed as Dec 21, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does ABVX pay a dividend?

ABVX's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.